PortalPublikationenPrevalence and impact of cannabis use disorders in adolescen...

Prevalence and impact of cannabis use disorders in adolescents with early onset first episode psychosis.

Standard

Prevalence and impact of cannabis use disorders in adolescents with early onset first episode psychosis. / Schimmelmann, Benno Graf; Conus, P; Cotton, S; Kupferschmid, S; McGorry, P D; Lambert, Martin.

in: EUR PSYCHIAT, Jahrgang 27, Nr. 6, 6, 2012, S. 463-469.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Schimmelmann, BG, Conus, P, Cotton, S, Kupferschmid, S, McGorry, PD & Lambert, M 2012, 'Prevalence and impact of cannabis use disorders in adolescents with early onset first episode psychosis.', EUR PSYCHIAT, Jg. 27, Nr. 6, 6, S. 463-469. <http://www.ncbi.nlm.nih.gov/pubmed/21616646?dopt=Citation>

APA

Schimmelmann, B. G., Conus, P., Cotton, S., Kupferschmid, S., McGorry, P. D., & Lambert, M. (2012). Prevalence and impact of cannabis use disorders in adolescents with early onset first episode psychosis. EUR PSYCHIAT, 27(6), 463-469. [6]. http://www.ncbi.nlm.nih.gov/pubmed/21616646?dopt=Citation

Vancouver

Schimmelmann BG, Conus P, Cotton S, Kupferschmid S, McGorry PD, Lambert M. Prevalence and impact of cannabis use disorders in adolescents with early onset first episode psychosis. EUR PSYCHIAT. 2012;27(6):463-469. 6.

Bibtex

@article{3819b8b015864fc5aebd9506fef0e166,
title = "Prevalence and impact of cannabis use disorders in adolescents with early onset first episode psychosis.",
abstract = "Previous studies on the impact of cannabis use disorders (CU) on outcome in psychosis were predominantly based on non representative samples, often have not controlled for confounders and rarely focused on adolescent patients. Thus, the aims of the present study were to assess: (i) prevalence of CU; (ii) baseline and pretreatment differences between CU and those without CU (NCU); (iii) the impact of baseline and course of CU on 18-month outcomes in a representative cohort of adolescents with early onset first episode psychosis (EOP).",
keywords = "Humans, Male, Female, Psychiatric Status Rating Scales, Adolescent, Questionnaires, Severity of Illness Index, Schizophrenic Psychology, Prevalence, Hospitalization, Australia/epidemiology, Marijuana Abuse/complications/*epidemiology, Psychotic Disorders/complications/*diagnosis, Humans, Male, Female, Psychiatric Status Rating Scales, Adolescent, Questionnaires, Severity of Illness Index, Schizophrenic Psychology, Prevalence, Hospitalization, Australia/epidemiology, Marijuana Abuse/complications/*epidemiology, Psychotic Disorders/complications/*diagnosis",
author = "Schimmelmann, {Benno Graf} and P Conus and S Cotton and S Kupferschmid and McGorry, {P D} and Martin Lambert",
year = "2012",
language = "English",
volume = "27",
pages = "463--469",
journal = "EUR PSYCHIAT",
issn = "0924-9338",
publisher = "Elsevier Masson",
number = "6",

}

RIS

TY - JOUR

T1 - Prevalence and impact of cannabis use disorders in adolescents with early onset first episode psychosis.

AU - Schimmelmann, Benno Graf

AU - Conus, P

AU - Cotton, S

AU - Kupferschmid, S

AU - McGorry, P D

AU - Lambert, Martin

PY - 2012

Y1 - 2012

N2 - Previous studies on the impact of cannabis use disorders (CU) on outcome in psychosis were predominantly based on non representative samples, often have not controlled for confounders and rarely focused on adolescent patients. Thus, the aims of the present study were to assess: (i) prevalence of CU; (ii) baseline and pretreatment differences between CU and those without CU (NCU); (iii) the impact of baseline and course of CU on 18-month outcomes in a representative cohort of adolescents with early onset first episode psychosis (EOP).

AB - Previous studies on the impact of cannabis use disorders (CU) on outcome in psychosis were predominantly based on non representative samples, often have not controlled for confounders and rarely focused on adolescent patients. Thus, the aims of the present study were to assess: (i) prevalence of CU; (ii) baseline and pretreatment differences between CU and those without CU (NCU); (iii) the impact of baseline and course of CU on 18-month outcomes in a representative cohort of adolescents with early onset first episode psychosis (EOP).

KW - Humans

KW - Male

KW - Female

KW - Psychiatric Status Rating Scales

KW - Adolescent

KW - Questionnaires

KW - Severity of Illness Index

KW - Schizophrenic Psychology

KW - Prevalence

KW - Hospitalization

KW - Australia/epidemiology

KW - Marijuana Abuse/complications/epidemiology

KW - Psychotic Disorders/complications/diagnosis

KW - Humans

KW - Male

KW - Female

KW - Psychiatric Status Rating Scales

KW - Adolescent

KW - Questionnaires

KW - Severity of Illness Index

KW - Schizophrenic Psychology

KW - Prevalence

KW - Hospitalization

KW - Australia/epidemiology

KW - Marijuana Abuse/complications/epidemiology

KW - Psychotic Disorders/complications/diagnosis

M3 - SCORING: Journal article

VL - 27

SP - 463

EP - 469

JO - EUR PSYCHIAT

JF - EUR PSYCHIAT

SN - 0924-9338

IS - 6

M1 - 6

ER -